Frank M. Longo, M.D., Ph.D.
- Posted on May 9, 2026
Dr. Longo is Chairman of the Board and Co-founder of PharmatrophiX. Dr. Longo received his MD in 1981 and PhD in Neurosciences in 1983 from UC San Diego. He completed his neurology training in the Department of Neurology at UC San Francisco where he was then recruited as an assistant professor and promoted to professor ... Read More
Anne Chun Longo
- Posted on May 8, 2026
Anne Chun Longo is Co-Founder of PharmatrophiX and served as its Founding CEO from 2006 to 2025. She currently serves as Senior Advisor, continuing to advance the company’s mission to develop novel therapeutics for neurodegenerative diseases. She brings more than 25 years of experience in academic medicine and development, most recently at Stanford University, where ... Read More
David Setboun, Pharm.D., MBA
- Posted on May 7, 2026
David Setboun, Pharm.D., MBA, is a life sciences CEO with more than 20 years of experience building and scaling biotech and pharmaceutical organizations across neurology, rare disease, oncology, and aging science. He has held senior leadership roles at Eli Lilly, AstraZeneca, and Biogen, where he led initiatives in corporate development, commercial strategy, and global operations, ... Read More
Louise F. Brady
- Posted on May 6, 2026
Louise F. Brady has served as a director since October 2023. Ms. Brady is the Co-Founder and Managing Partner of Piedmont Capital Partners, LLC; Piedmont Capital Partners II, LLC; and Piedmont Capital Investments, LLC (collectively with their affiliated entities, “Piedmont Capital”) since 2013, 2019, and 2020, respectively. Piedmont Capital invests in privately held companies focused ... Read More
Robert B. Sims, M.D.
- Posted on May 5, 2026
Robert Sims, MD, has been on the Board of Directors at PharmatrophiX since 2017. He is board certified in Internal Medicine, Hematology, and Medical Oncology. He has over 25 years of clinical research experience in the biotech and pharmaceutical industry, including senior roles at Dendreon, Seagen, and Pfizer. He received his medical degree from Oregon ... Read More